Synapse

← Cancer Treatment and Research Communications

Papers in Cancer Treatment and Research Communications

Page 11 · newest first

  1. Surgical margin and local recurrence of ductal carcinoma in situCancer Treatment and Research Communications · 2024
  2. Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizonsCancer Treatment and Research Communications · 2024
  3. Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer—A prospective studyCancer Treatment and Research Communications · 2024
  4. Unveiling the genetic landscape of hereditary melanoma: From susceptibility to surveillanceCancer Treatment and Research Communications · 2024
  5. Early onset metastatic colorectal cancer in AustraliaCancer Treatment and Research Communications · 2024
  6. The Impact of Bleomycin Deficit on Survival in Hodgkin's Lymphoma Patients: A Retrospective StudyCancer Treatment and Research Communications · 2024
  7. Exploring vismodegib: A non-surgical breakthrough in the management of advanced periocular basal cell carcinomaCancer Treatment and Research Communications · 2024
  8. Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy eraCancer Treatment and Research Communications · 2024
  9. A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinomaCancer Treatment and Research Communications · 2024
  10. Warfarin intake in relation to diagnosis reduces mortality in patients with colorectal cancer – a register-based studyCancer Treatment and Research Communications · 2024
  11. Rectal cancer survival and prognostic factors in Iranian population: A retrospective cohort studyCancer Treatment and Research Communications · 2024
  12. "Evaluating Current Diagnostic and Treatment Challenges in Colorectal Cancer: Strategies for improving care and outcomes in Georgia"Cancer Treatment and Research Communications · 2024
  13. Clinical and pathological differences between early- and late-onset colorectal cancer and determinants of one-year all-cause mortality among advanced-stage patients: a retrospective cohort study in Medellín, ColombiaCancer Treatment and Research Communications · 2024
  14. Targeting transforming growth factor-β1 by methylseleninic acid/seleno-L-methionine in clear cell renal cell carcinoma: Mechanisms and therapeutic potentialCancer Treatment and Research Communications · 2024
  15. The real-world insights on the use, safety, and outcome of immune-checkpoint inhibitors in underrepresented populations with lung cancerCancer Treatment and Research Communications · 2024
  16. Investigation of the association between the CASP8rs1045485 and SOD2 rs4880 single nucleotide polymorphisms (SNPs) with breast cancerCancer Treatment and Research Communications · 2024
  17. PARP inhibitors as therapy for small cell lung carcinoma: A systematic review and meta-analysis of clinical trialsCancer Treatment and Research Communications · 2024
  18. Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancerCancer Treatment and Research Communications · 2024
  19. Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugsCancer Treatment and Research Communications · 2024
  20. Comprehensive structural and functional analysis of hVEGFR1: Insights into phosphorylation, molecular interactions, and potential inhibitors through docking and dynamics simulationsCancer Treatment and Research Communications · 2024
  21. Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studiesCancer Treatment and Research Communications · 2024
  22. Considerations for selecting second-line treatment in patients with progressive small cell lung cancer and the use of Lurbinectedin in this settingCancer Treatment and Research Communications · 2024
  23. Assessing Providers’ knowledge about and barriers to lung cancer screeningCancer Treatment and Research Communications · 2024
  24. Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief reportCancer Treatment and Research Communications · 2024
  25. WGCNA and integrative network analysis identify CHRNA5 and CTLA4 as potential therapeutic targets against angiosarcomaCancer Treatment and Research Communications · 2024
  26. Diagnostic performance of digital breast tomosynthesis (DBT) versus digital mammography (DM) in a population clinically referred for breast imaging – a retrospective cohort studyCancer Treatment and Research Communications · 2024
  27. Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trialCancer Treatment and Research Communications · 2024
  28. Sarcopenia in gastric cancer and its impact on early postoperative outcomeCancer Treatment and Research Communications · 2024
  29. Low to intermediate grade lung neuroendocrine tumours. A single centre real world experienceCancer Treatment and Research Communications · 2024
  30. On-body injector pegfilgrastim for chemotherapy-induced neutropenia prophylaxis: Current StatusCancer Treatment and Research Communications · 2024
  31. The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic reviewCancer Treatment and Research Communications · 2024
  32. An evaluation of the utility of computed tomography in high-risk endometrial cancer surveillanceCancer Treatment and Research Communications · 2024
  33. Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label studyCancer Treatment and Research Communications · 2024
  34. Tailoring treatment for locally advanced rectal cancerCancer Treatment and Research Communications · 2024
  35. The prevalence and prognostic significance of Sarcopenia and Adipopenia in Pleural MesotheliomaCancer Treatment and Research Communications · 2024
  36. Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, EthiopiaCancer Treatment and Research Communications · 2024
  37. A brief report on stable disease among amivantamab-treated patients with post-platinum epidermal growth factor receptor exon 20 insertion–mutated non-small cell lung cancer: A response-based analysis from the CHRYSALIS studyCancer Treatment and Research Communications · 2024
  38. Assessing the role of MSH2 and MSH6 gene expression deficiency in prostate cancer progression, a cross-sectional studyCancer Treatment and Research Communications · 2024
  39. En plaque meningioma of the temporal bone: A systematic review on the imaging and management of a rare tumorCancer Treatment and Research Communications · 2024
  40. Development of a c-MET x CD137 bispecific antibody for targeted immune agonism in cancer immunotherapyCancer Treatment and Research Communications · 2024
  41. Prediction of villin expression and tumor behavior in colorectal cancerCancer Treatment and Research Communications · 2024
  42. Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patientsCancer Treatment and Research Communications · 2024
  43. Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancerCancer Treatment and Research Communications · 2024
  44. Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classificationCancer Treatment and Research Communications · 2024
  45. EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB–IIIA non-small cell lung cancer in Norway–a nationwide cohort studyCancer Treatment and Research Communications · 2023
  46. Tumor circulating biomarkers in colorectal cancerCancer Treatment and Research Communications · 2023
  47. Pregnancy-related breast cancer: 14-year experience in a tertiary institution in Hong KongCancer Treatment and Research Communications · 2023
  48. The symptom burden of women with a known risk of breast cancer receiving risk reducing medicationCancer Treatment and Research Communications · 2023
  49. Assessing knowledge, attitude and practice towards prostate cancer screening among males in Southwest Tanzania: A cross-sectional studyCancer Treatment and Research Communications · 2023
  50. Real-world palbociclib effectiveness in patients with metastatic breast cancer: Focus on neutropenia-related treatment modification strategies and clinical outcomesCancer Treatment and Research Communications · 2023